Welcome to the Library, where you'll find a selection of industry resources including eBooks, Whitepapers, Webinars, Survey Reports, Research Reports and more.
If you are interested in submitting items to the Library, please contact our advertising team
This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. This series provides an overview of the science and technology used to enable discovery and the processes scientists use to discover new therapeutics. Download now.
Subject matter experts from Remedy Informatics will describe an integrated system and innovative biomedical informatics platform that collects, aggregates, maps and harmonizes biospecimen, laboratory, clinical and study data throughout the bench-to-bedside cycle. Register today
There are several new initiatives being undertaken in the biopharmaceutical industry aimed at making better use of the vast terabytes of information flowing out of research labs around the world. This ebook discusses the intelligent application of analytics and informatics to enable drug hunters to better understand disease, pharmacological and clinical data. Download it today.
The FDA has finally issued new guidance outlining requirements for mobile medical device apps. Are companies altering their app development in response to the new requirements, or can they continue as planned, business as usual? This webinar explores the issue. Register Today!
The cost of drugs that fail in clinical trials can be measured by far more than the cash poured into the development process. Now, through drug repositioning some of those investment costs can be recouped by giving drugs a second and often lower-risk chance in a new indication. Download this FierceBiotech ebook to learn key advantages and strategies of drug repositioning.
Biomarkers have been used in the diagnosis and monitoring of kidney disease for many years. However, these are most effective in established disease, and by the time they detect injury, the damage may already be done. This ebook discusses the use of biomarkers in identifying susceptibility to kidney disease, using biomarkers to predict outcomes, as well as the limitations of existing biomarkers. Learn more.
Beyond Regulations: Developing a Post-Approval Strategy and Plan to Support a Product Throughout its Lifecycle
In this session, we will discuss the market changes driving this demand for evidence, and opportunities for generating and leveraging high-quality late-phase data to optimize product life cycle management. Register to watch now.
There's no denying the power and promise of next-generation DNA sequencing (NGS) in the healthcare setting. Since 2005, when the first next-gen instruments hit the market, the field has exploded, and not surprisingly, companies have stepped in to fill unmet clinical needs. Here, we profile five businesses taking five different approaches to clinical NGS. Download today.
Choosing the right country and site for successful patient recruitment is a critical step for entire drug development program. Join us as we address a unique way to leverage informatics insights for optimizing oncology clinical trial site selection based upon consistency of performance and quality indicators across trials. Register to watch now!
Join Thomson Reuters as they discuss how they effectively mine molecular data in biomarker discovery for precision medicine. Find out how network and pathway information can be used for identification of biomarker signatures and discover how MetaBase content integration works with these approaches. Register to watch now!
Is automated monitoring the solution to enable efficient partnership and acquisition decisions? Join us as we discuss this and much more with panelists from Inova, Versant EuroVentures and Thomson Reuters. Gain deep insights into how technology is changing the face of opportunity monitoring. Register to watch now!
Sarah Aerni from Pivotal Data Science Labs, and E. Sasha Paegle from EMC Isilon discuss RNA-seq data management and analysis strategies for minimizing bottlenecks during alignment, splice junction detection, and gene expression quantification. Register to watch now!
Topics for this webinar will include insights about implementing a scalable storage infrastructure, experience with data retention and back up policies, and the trade-offs of transmitting data at scale. Register to watch now!
Now that drugmakers have armed reps and other commercial staffers with the devices, they need to give them to proper tools to manage their relationships in the field and analyze increasing amounts of strategic data. Join as we discuss this topic and answer some pressing questions about mobile. Register to watch now!
The life sciences industry is one of the most heavily regulated, and the changes won't stop coming as long as lawmakers and regulators have anything to do with it. This webinar will provide the information and guidance you need from our panel of regulatory specialists, compliance professionals and industry experts. Register to watch now!
The rapid advances in the application of next generation sequencing for translational research are driving the dramatic rethinking and re-architecting of IT infrastructures that will enable moving and sharing of genomic data more broadly. EMC Isilon and Globus Online discuss the merits of Globus Genomics. Register to watch now!
As pursuit of biosimilars grows, companies continue to search for efficiencies in getting products through the development stage and to market as quickly as possible. Join as we discuss how using a seamless development strategy combined with a Bayesian statistical approach could reduce development time and cost. Register to watch now!
The mobile health market is moving rapidly, with apps now helping patients collect health data and physicians tapping into that data remotely. Join as we examine mobile health advances, patient privacy challenges, and how the FDA is evolving its thinking on regulating mobile apps. Register to watch now!
In order to accelerate the production of biological molecules, companies have been exploring disposable, single-use systems. Download this ebook to learn the impact and future use of single-use technologies, cost-saving opportunities, and challenges of implementing new drug development processes.
Faced with a continuing economic crisis and an aging and increasingly obese population, healthcare providers are seeing where they can cut costs. Generics saved the U.S. healthcare system $192 billion in 2011 alone. To read more on this timely topic, download this eBook today.
The Chinese government's devotion to biotech has sparked major expansion efforts by some of the country's leading pharmaceutical players, also making it fertile ground for venture capitalists in the U.S. Click here to download the complete report today.
In recent years, researchers and companies have faced increasing challenges in the discovery and development of new drugs. The challenge for Pharma companies has become maximizing the bioavailability of molecules that demonstrate activity, but are often poorly soluble and/or permeable, by selection and careful utilization of the right drug delivery technologies. Click here to download this eBook today.
For the drug developers looking to bring these products to market, ADCs represent the inevitable marriage of two sometimes hit-or-miss technologies, chemotherapy and antibodies, the next generation of anti-cancer compounds. In this Special Report FierceBiotech explores the potential and the challenges of the burgeoning field of ADCs.